These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 17642126)

  • 1. Who owns the long term? Perspectives from global business leaders.
    Lévy M; Eskew M; Bernotat WH; Barner M
    Harv Bus Rev; 2007; 85(7-8):54-60, 191. PubMed ID: 17642126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Back where we belong.
    Critelli MJ
    Harv Bus Rev; 2005 May; 83(5):47-54, 152. PubMed ID: 15929403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainable growth, the DuPont way.
    Holliday C
    Harv Bus Rev; 2001 Sep; 79(8):129-34, 162. PubMed ID: 11550629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The five messages leaders must manage.
    Hamm J
    Harv Bus Rev; 2006 May; 84(5):114-23, 158. PubMed ID: 16649703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CEO as organizational architect: an interview with Xerox's Paul Allaire. Interview by Robert Howard.
    Allaire P
    Harv Bus Rev; 1992; 70(5):106-21. PubMed ID: 10121313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2003 HBR list. Breakthrough ideas for tomorrow's business agenda.
    Harv Bus Rev; 2003 Apr; 81(4):92-8, 124. PubMed ID: 12687923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new deal at the top.
    Doz YL; Kosonen M
    Harv Bus Rev; 2007 Jun; 85(6):98-104, 142. PubMed ID: 17580652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Master of the house: Why a company should take control of its building projects.
    Thurm D
    Harv Bus Rev; 2005 Oct; 83(10):120-9, 158. PubMed ID: 16250630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's a business for?
    Handy C
    Harv Bus Rev; 2002 Dec; 80(12):49-55, 132. PubMed ID: 12510537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why entrepreneurs don't scale.
    Hamm J
    Harv Bus Rev; 2002 Dec; 80(12):110-5, 134. PubMed ID: 12510543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The competitive advantage of corporate philanthropy.
    Porter ME; Kramer MR
    Harv Bus Rev; 2002 Dec; 80(12):56-68, 133. PubMed ID: 12510538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. We don't need another hero.
    Badaracco JL
    Harv Bus Rev; 2001 Sep; 79(8):120-6, 162. PubMed ID: 11550628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp.
    Sharer K
    Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leadership and the psychology of turnarounds.
    Kanter RM
    Harv Bus Rev; 2003 Jun; 81(6):58-67, 136. PubMed ID: 12800717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead for loyalty.
    Reichheld FF
    Harv Bus Rev; 2001; 79(7):76-84, 144. PubMed ID: 11447619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving mountains.
    Harv Bus Rev; 2003 Jan; 81(1):41-7. PubMed ID: 12545921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy as ecology.
    Iansiti M; Levien R
    Harv Bus Rev; 2004 Mar; 82(3):68-78, 126. PubMed ID: 15029791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High tech the old-fashioned way. An interview with Tom Siebel of Siebel Systems. Interview by Bronwyn Fryer.
    Siebel T
    Harv Bus Rev; 2001 Mar; 79(3):118-25, 165. PubMed ID: 11246919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building a leadership brand.
    Ulrich D; Smallwood N
    Harv Bus Rev; 2007; 85(7-8):92-100, 192. PubMed ID: 17642128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The turnaround value of values.
    Thorbeck J
    Harv Bus Rev; 1991; 69(1):52-4, 56-8, 60-2. PubMed ID: 10109472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.